FT Vest U.S. Equity Deep Buffer ETF – October (BATS:DOCT) Trading 0.5% Higher – Here’s What Happened

FT Vest U.S. Equity Deep Buffer ETF – October (BATS:DOCT)’s stock price rose 0.5% on Monday . The company traded as high as $40.13 and last traded at $40.25. Approximately 21,075 shares changed hands during mid-day trading, The stock had previously closed at $40.05.

FT Vest U.S. Equity Deep Buffer ETF – October Stock Up 0.8 %

The stock has a market capitalization of $196.91 million, a price-to-earnings ratio of 23.49 and a beta of 0.46. The business has a 50-day simple moving average of $39.78 and a two-hundred day simple moving average of $39.31.

Institutional Investors Weigh In On FT Vest U.S. Equity Deep Buffer ETF – October

Several hedge funds have recently made changes to their positions in DOCT. Arkadios Wealth Advisors purchased a new position in shares of FT Vest U.S. Equity Deep Buffer ETF – October during the 4th quarter valued at $214,000. Sunbelt Securities Inc. lifted its position in FT Vest U.S. Equity Deep Buffer ETF – October by 129.7% during the 3rd quarter. Sunbelt Securities Inc. now owns 3,515 shares of the company’s stock worth $137,000 after acquiring an additional 1,985 shares during the last quarter. AlphaMark Advisors LLC boosted its stake in FT Vest U.S. Equity Deep Buffer ETF – October by 223.4% during the 4th quarter. AlphaMark Advisors LLC now owns 1,520 shares of the company’s stock valued at $60,000 after purchasing an additional 1,050 shares during the period. Finally, Creative Financial Designs Inc. ADV grew its stake in shares of FT Vest U.S. Equity Deep Buffer ETF – October by 40.6% in the fourth quarter. Creative Financial Designs Inc. ADV now owns 1,326 shares of the company’s stock worth $52,000 after acquiring an additional 383 shares during the last quarter.

About FT Vest U.S. Equity Deep Buffer ETF – October

The FT Cboe Vest U.S. Equity Deep Buffer ETF – October (DOCT) is an exchange-traded fund that mostly invests in large cap equity. The fund aims for specific buffered losses and capped gains on the SPY over a specific holdings period. The actively-managed fund holds options and collateral. DOCT was launched on Oct 16, 2020 and is managed by First Trust.